Advanced Sperm Selection Techniques and Their Contribution to Blastocyst Euploidy Rates
NCT ID: NCT05494216
Last Updated: 2024-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
515 participants
INTERVENTIONAL
2022-08-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Preimplantation Genetic Diagnosis for Sex Selection Affect the Pregnancy and Miscarriage Rates in Women With an Expected Good Ovarian Response Undergoing IVF/ICSI Cycles?
NCT02149251
Sperm DNA Fragmentation Effects on Blastocyst Morphology Grading, Pregnancy Rate and Implantation Rate
NCT04144621
Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos
NCT04280757
A New Micro Swim-up Procedure for Sperm Preparation in ICSI Treatment
NCT02672124
Effectiveness of PGT-A: IVF Versus ICSI
NCT03708991
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PGT-A cases will be randomized on the day of ICSI to the 2 assigned sperm selection techniques.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PICSI
Semen processing is done by double layer density gradient method followed by adding Sperm to the dot of hyaluronan on the PICSI dish, within minutes the bound sperm are attached by their acrosome to the surface of the dot. Individual bound sperm selection is done followed y ICSI
PICSI
Sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index
MACS
Semen processing is done by double layer density gradient method. The resulted pellet is labeled with annexin V microbeads followed by separation on MACS Column, the eluted fraction contains non apoptotic sperm suitable for ICSI.
MACS
Sperm selection using MACS for selecting sperm with lower DNA fragmentation index
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PICSI
Sperm selection using PICSI dish for selecting sperm with lower DNA fragmentation index
MACS
Sperm selection using MACS for selecting sperm with lower DNA fragmentation index
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males diagnosed with abnormal sperm DNA fragmentation index (\> 20%).
* Normo responder (\> 5 mature oocytes)
* Male will have to refrain from ejaculation no less than 1 day but no greater than 3 days prior semen specimen production on day of ICSI
Exclusion Criteria
* Presence of varicocele.
* Known genetic abnormality
* Use of sperm or oocyte donors
* Use of gestational carrier
* Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection
* Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ganin Fertility Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eman Hasanen, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Manar Hozayen, MSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Amr Elshimy, BSc.
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hanaa Alkhader, MBBS/MD
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Hosam Zaki, MSc, FRCOG
Role: STUDY_DIRECTOR
Ganin Fertility Center
Yara Hazem, BP
Role: PRINCIPAL_INVESTIGATOR
Ganin Fertility Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ganin Fertility Center
Cairo, Maadi, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFC-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.